IT8148649A0 - Procedimento per la produzione di nuovi mutanti di virus di herpessimplex tipo 1 e tipo 2 - Google Patents

Procedimento per la produzione di nuovi mutanti di virus di herpessimplex tipo 1 e tipo 2

Info

Publication number
IT8148649A0
IT8148649A0 IT8148649A IT4864981A IT8148649A0 IT 8148649 A0 IT8148649 A0 IT 8148649A0 IT 8148649 A IT8148649 A IT 8148649A IT 4864981 A IT4864981 A IT 4864981A IT 8148649 A0 IT8148649 A0 IT 8148649A0
Authority
IT
Italy
Prior art keywords
type
herpessimplex
virus
procedure
production
Prior art date
Application number
IT8148649A
Other languages
English (en)
Inventor
Kailash K Gauri
Original Assignee
Asta Werke Ag Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke Ag Chem Fab filed Critical Asta Werke Ag Chem Fab
Publication of IT8148649A0 publication Critical patent/IT8148649A0/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661Methods of inactivation or attenuation
    • C12N2710/16663Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT8148649A 1980-06-12 1981-06-10 Procedimento per la produzione di nuovi mutanti di virus di herpessimplex tipo 1 e tipo 2 IT8148649A0 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8019308 1980-06-12

Publications (1)

Publication Number Publication Date
IT8148649A0 true IT8148649A0 (it) 1981-06-10

Family

ID=10514018

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8148649A IT8148649A0 (it) 1980-06-12 1981-06-10 Procedimento per la produzione di nuovi mutanti di virus di herpessimplex tipo 1 e tipo 2

Country Status (7)

Country Link
US (1) US4322404A (it)
BE (1) BE889182A (it)
DE (1) DE3122669A1 (it)
ES (1) ES502965A0 (it)
FR (1) FR2484446A1 (it)
IT (1) IT8148649A0 (it)
NL (1) NL8102827A (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
USRE33772E (en) * 1983-10-12 1991-12-17 Centraal Diergeneeskundig Instituut Deletion mutant of a herpesvirus and vaccine containing said virus
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
US5585096A (en) * 1994-06-23 1996-12-17 Georgetown University Replication-competent herpes simplex virus mediates destruction of neoplastic cells
US6471965B1 (en) * 1994-07-27 2002-10-29 Bio-Virus Research Incorporated Vaccine containing whole killed herpes viruses to prevent development of atherosclerotic plaque
US5837262A (en) * 1994-07-27 1998-11-17 Bio-Virus Research Incorporated Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
CN101058800B (zh) * 2002-07-09 2013-03-13 巴克斯特国际有限公司 用于细胞培养的无动物蛋白质培养基

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR216081A1 (es) * 1976-07-02 1979-11-30 Dso Pharmachim Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung

Also Published As

Publication number Publication date
BE889182A (fr) 1981-12-11
NL8102827A (nl) 1982-01-04
ES8303522A1 (es) 1983-02-01
FR2484446A1 (fr) 1981-12-18
DE3122669A1 (de) 1982-02-11
ES502965A0 (es) 1983-02-01
US4322404A (en) 1982-03-30

Similar Documents

Publication Publication Date Title
IT1191150B (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo
IT1154270B (it) Procedimento per la produzione di virus vaccini
FI813058L (fi) Foerbaettringar beroerande 2,4-disubstituerade tiazolderivat
IT1152146B (it) Procedimento per la produzione di nerofumo
IT1163008B (it) Composizione e procedimento per la produzione di composta
IT1171520B (it) Procedimento per la preparazione di 2-ammino-3-carbetossiammino-6-(p-fluor-benzilammino)-piridin-maleato dotato di proprieta' farmacologiche e prodotto ottenuto
IT8124141A0 (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
IT1154271B (it) Procedimento per la produzione di disolfuri di tiurama sostituiti
IT8148649A0 (it) Procedimento per la produzione di nuovi mutanti di virus di herpessimplex tipo 1 e tipo 2
IT1154275B (it) Procedimento per la produzione di disolfuri di tiurame
IT8148830A0 (it) Procedimento per la produzione di 2-metilenaldeidi
IT1147923B (it) Procedimento per la produzione di ditiazolil-2(2.2')-disolfuri
FI813666L (fi) Foerfarande foer framstaellning av 3,4-bis-substituerade 1,2,5-oxdiazol-2-oxider
IT1172398B (it) Procedimento per la produzione di 1,2-diclorcetano
IT1179025B (it) Procedimento per la produzione di l'isoleucina
IT1157058B (it) Procedimento per la preparazione di acril e metaacrilamidi n.sostituite
IT8124185A0 (it) Procedimento ed apparecchiatura per la realizzazione di cerniere lampo.
IT8120167A0 (it) Procedimento per la produzione di particelle di gel ed apparecchiatura per l'attuazione di detto procedimento.
IT1172073B (it) Procedimento per la preparazione di buspirone
IT1170744B (it) Procedimento per la produzione di o-trimetil-sililcellulose
IT1192483B (it) Kanamicine 2'-modificate e produzione di queste
IT1190971B (it) Procedimento per la produzione di 2-ammino-4-idrossi-5-alogeno-pirimidine
IT1141061B (it) Procedimento per la produzione di uricasi
IT1170745B (it) Procedimento per la produzione di o-trimetilsilicellulose
IT1155455B (it) Procedimento per la preparazione di imidazolilvinileteri